GLOBLVIEW
← All stock pages

UnitedHealth (UNH): healthcare and rate exposure

UnitedHealth // Health Care // the United States
By Mateo Murr · Last reviewed 5 Oct 2026
Track UNH in GLOBLVIEW
Free, no account needed.
Last
$410.91
Day
+0.94%
Open
$413.71
High
$414.76
Low
$404.31
Prev
$407.10
436.35259.02
1 year price history, close only.

How global shocks reach UNH

None of the tracked sector channels map to UnitedHealth (Health Care), so only geography applies. Stories centered on the United States register as exposure, because the company is registered in the United States.

Direction is a tendency across cycles, not a forecast. Sector mapping uses the Finnhub industry classification; geography uses country of registration, not revenue by region.

What actually moves UnitedHealth

UnitedHealth is a policy and medical-cost company that happens to carry a large debt stack. Commercial paper and long-term debt principal totaled $79.4 billion, with $6.1 billion due in 2026 and interest expense of $4.0 billion. Rates also affect the portfolio that holds premiums before claims are paid. Neither path is why operating earnings fell to $19.0 billion from $32.3 billion. The filing points to utilization, billing intensity and costly drugs against premiums that had already been priced.

The payer that dominates is the federal government. CMS premiums were 44% of consolidated revenue, up from 40%. Medicare Advantage benchmark changes, risk-adjustment audits and star ratings move the book more than oil, conflict or chips. A recession reaches it through employers cutting coverage, which the filing names.

Tariffs belong only if they raise drug or device prices enough to lift medical cost trend. That is an indirect path. The less obvious operational scar is Change Healthcare. The filing cites the 2024 cyberattack and says recently acquired businesses can carry extra vulnerability. Optum Health swung to an operating loss in 2025. A macro badge will not explain that swing.

Drawn from the annual filing cited below. Not a forecast and not investment advice.

What UnitedHealth sells and where it earns

UnitedHealth Group has two businesses. UnitedHealthcare sells health coverage: employer and individual plans, Medicare Advantage and Part D through its Medicare & Retirement unit, and Medicaid plans through Community & State. Optum sells health services and is split three ways. Optum Health delivers care through employed and affiliated physicians and runs value-based arrangements in which it takes on the cost of a patient's care. Optum Insight sells software, data analytics and administrative services to hospitals, health plans, state governments and life sciences companies. Optum Rx is a pharmacy benefit manager and pharmacy business. Much of Optum's revenue comes from UnitedHealthcare itself: $168.0 billion of Optum's $270.6 billion of 2025 revenue was intercompany. Consolidated revenue was $447.6 billion, but earnings from operations fell to $19.0 billion from $32.3 billion, and Optum Health swung to a $278 million operating loss. Premiums from risk-based products make up nearly 80% of revenue, so small misses in forecasting medical costs move profits sharply. The company had more than 390,000 employees at year end.

Revenue by segment, FY2025, year ended December 31, 2025
UnitedHealthcare (Revenue from outside customers, almost all premiums.)77%
Optum Rx (Outside customers only. Total segment revenue including UnitedHealthcare was $154.7 billion.)13%
Optum Health (Outside customers only. Total segment revenue was $102.0 billion, with an operating loss in 2025.)8%
Optum Insight (Outside customers only. Total segment revenue was $19.4 billion. Investment income makes up the remaining 1%.)1%
Revenue by geography
United States (no geographic split disclosed; South American businesses held for sale at year end)Not broken out

Customer concentration

Premium revenues from CMS were 44% of consolidated revenue in 2025, up from 40% in 2024 and 2023, most of it from UnitedHealthcare Medicare & Retirement. The federal government is by far the largest payer, so Medicare Advantage and Part D funding decisions carry more weight than any commercial account.

Debt

Commercial paper and long-term debt principal totaled $79.4 billion at December 31, 2025, with $6.1 billion due in 2026 and between $3.5 billion and $3.9 billion due in each year from 2027 through 2030; $58.7 billion is due after 2030. Interest expense was $4.0 billion in 2025.

Risk factors that moved this year

How this changes the exposure read

UnitedHealth is a policy stock more than a macro one. CMS premiums were 44% of revenue, so Medicare Advantage rate notices, risk adjustment changes and audits move it more than any of the six tracked shocks. Rates and Fed policy matter through the investment portfolio that holds premiums before claims are paid and through $79.4 billion of debt. Credit stress and recession act through employers cutting coverage, which the filing names as a risk. Oil, conflict and chip shocks have little direct reach. Tariffs that raise drug or device prices would feed medical costs, which the filing lists as a cost driver. The defensive sector label hides how sharply cost trend can swing profits.

Source: UnitedHealth Group 10-K, FY2025. Checked 2026-10-05. Figures are from the filing and may differ from the live stats above.

What is moving it now

Vance outreach to Iran related to medical supplies, says Trump - Reuters
WASHINGTONGeographyregistered in US, where this story is centredReuters · 4h ago
Polymarket reports outage on international exchange, halts trading
WASHINGTONGeographyregistered in US, where this story is centredCNBC · 6h ago
Fed chairman talks tough on inflation — plus, what's behind Micron's big rally
WASHINGTONGeographyregistered in US, where this story is centredCNBC · 1d ago
Bond investor Jeff Gundlach talks to CNBC about Fed's rate pause, Warsh reducing vote-setting meetings
WASHINGTONGeographyregistered in US, where this story is centredCNBC · 1d ago
Explainer: What's at stake for Trump in Israel's deadlocked election? - Reuters
WASHINGTONGeographyregistered in US, where this story is centredReuters · 1d ago
Brazil Supreme Court says no search warrant issued against Senator Flavio Bolsonaro - Reuters
WASHINGTONGeographyregistered in US, where this story is centredReuters · 1d ago

Key stats

Market cap$366.90B
P/E (TTM)23.05x
EV/EBITDA14.79x
P/S (TTM)0.81x
P/B3.16x
EPS (TTM)$17.52
Div yield2.23%
Beta0.54
52W high$461.62
52W low$255.97
Avg vol (10d)5.56M
Avg vol (3m)5.30M
Oper margin5.25%
Net margin3.53%
ROE16.10%
Rev growth YoY3.33%
Debt/Equity0.71x
Next earnings25 Jan 2027

Recent filings

8-KCurrent report2026-10-13
8-KCurrent report2026-09-08
10-QQuarterly report2026-08-10
8-KCurrent report2026-07-16
8-KCurrent report2026-06-05
8-KCurrent report2026-05-11
10-QQuarterly report2026-05-05
8-KCurrent report2026-04-21
8-KCurrent report2026-03-09
8-KCurrent report2026-03-02
10-KAnnual report2026-03-02
8-KCurrent report2026-02-25

Related tickers

LLYJNJMRKABBVABT
The reasoning behind these mappings
Track UNH in GLOBLVIEW

Quotes may be delayed. Information only, not investment advice.